1. Changes in brain kynurenine levels via gut microbiota and gut‐barrier disruption induced by chronic ethanol exposure in mice
- Author
-
Giménez Gómez, Pablo, Pérez Hernández, Mercedes, O'Shea Gaya, María Esther, Caso Fernández, Javier Rubén, Martín Hernández, David, Alou Cervera, Luis, Gómez-Lus Centelles, María Luisa, Gutiérrez López, María Dolores, Colado Megías, María Isabel, Giménez Gómez, Pablo, Pérez Hernández, Mercedes, O'Shea Gaya, María Esther, Caso Fernández, Javier Rubén, Martín Hernández, David, Alou Cervera, Luis, Gómez-Lus Centelles, María Luisa, Gutiérrez López, María Dolores, and Colado Megías, María Isabel
- Abstract
Inflammatory processes have been shown to modify tryptophan (Trp) metabolism. Gut microbiota appears to play a significant role in the induction of peripheral and central inflammation. Ethanol (EtOH) exposure alters gut permeability, but its effects on Trp metabolism and the involvement of gut microbiota have not been studied. We analyzed several parameters of gut-barrier and of peripheral and central Trp metabolism following 2 different EtOH consumption patterns in mice, the binge model, drinking in the dark (DID), and the chronic intermittent (CI) consumption paradigm. Antibiotic treatment was used to evaluate gut microbiota involvement in the CI model. Mice exposed to CI EtOH intake, but not DID, show bacterial translocation and increased plasma LPS immediately after EtOH removal. Gut-barrier permeability to FITC-dextran is increased by CI, and, furthermore, intestinal epithelial tight-junction (TJ) disruption is observed (decreased expression of zonula occludens 1 and occludin) associated with increased matrix metalloproteinase (MMP)-9 activity and iNOS expression. CI EtOH, but not DID, increases kynurenine (Kyn) levels in plasma and limbic forebrain. Intestinal bacterial decontamination prevents the LPS increase but not the permeability to FITC-dextran, TJ disruption, or the increase in MMP-9 activity and iNOS expression. Although plasma Kyn levels are not affected by antibiotic treatment, the elevation of Kyn in brain is prevented, pointing to an involvement of microbiota in CI EtOH-induced changes in brain Trp metabolism. Additionally, CI EtOH produces depressive-like symptoms of anhedonia, which are prevented by the antibiotic treatment thus pointing to an association between anhedonia and the increase in brain Kyn and to the involvement of gut microbiota.-Giménez-Gómez, P., Pérez-Hernández, M., O'Shea, E., Caso, J. R., Martín-Hernández, D., Cervera, L. A., Centelles. M. L. G.-L., Gutiérrez-Lopez, M. D., Colado, M. I. Changes in brain kynurenine levels via g, Ministerio de Economia y Competitividad (España), Ministerio de Sanidad, Servicios Sociales e Igualdad, Instituto de Salud Carlos III Redes Temáticas de Investigación Cooperativa en Salud-Red de Trastornos Adictivos, Universidad Complutense de Madrid, Depto. de Medicina, Depto. de Farmacología y Toxicología, Fac. de Medicina, TRUE, pub
- Published
- 2024